Onderneming Baxter International Inc. Börse Stuttgart
Aandelen
BTL
US0718131099
Medische apparatuur, benodigdheden & distributie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
31,35 EUR | +0,11% | +0,66% | -9,62% |
Vakgebied
- geneesmiddelen en medische hulpmiddelen (33,8%): producten bestemd voor de behandeling van hemofilie (substitutiestollingsfactoren) en immuundeficiënties (multifunctionele immunoglobines), en gebruikt op de intensive care (menselijke albumine) en in de biochirurgie (fibrinelijm, chirurgische gel, botsubstituten, hemostatische kompressen, enz;)
- medicijnen en apparatuur voor nierdialyse (30,1%);
- systemen voor het toedienen van medicijnen en intraveneuze therapie (15,2%): gebruikt op het gebied van anesthesie, oncologie (chemotherapie en bestraling), parenterale voeding, enz;
- overige (20,1%).
Export is goed voor 52,7% van de netto-omzet.
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Medical Products and Therapies
33,8
%
| - | - | 5 011 | 33,8 % | - |
Kidney Care
30,1
%
| - | - | 4 453 | 30,1 % | - |
Healthcare Systems and Technologies
20,3
%
| - | - | 3 013 | 20,3 % | - |
Pharmaceuticals
15,2
%
| - | - | 2 249 | 15,2 % | - |
Other
0,6
%
| - | - | 87 | 0,6 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
47,3
%
| 7 223 | 47,8 % | 7 000 | 47,3 % | -3,09% |
Rest of World
30,3
%
| - | - | 4 494 | 30,3 % | - |
Emerging Markets
22,4
%
| - | - | 3 319 | 22,4 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 01-10-15 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 18-10-23 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Tobi Karchmer
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-19 |
Heather Knight
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-19 |
Clare Trachtman
IRC | Investor Relations Contact | - | 01-01-00 |
David Rosenbloom
LAW | General Counsel | - | 01-01-22 |
Darren Evans
PRN | Corporate Officer/Principal | - | 01-12-21 |
Heather Wechet
HRO | Human Resources Officer | - | 01-06-08 |
Lynn Pawelski
LAW | General Counsel | - | 01-04-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 06-02-17 |
Peter Wilver
BRD | Director/Board Member | 64 | 10-05-22 |
Director/Board Member | 64 | 18-02-19 | |
Director/Board Member | 63 | 01-01-19 | |
Joe Almeida
CEO | Chief Executive Officer | 61 | 01-10-15 |
Catherine Smith
BRD | Director/Board Member | 60 | 18-07-17 |
Director/Board Member | 69 | 13-12-21 | |
Director/Board Member | 66 | 21-08-23 | |
David Wilkes
BRD | Director/Board Member | 67 | 15-02-21 |
D. Shafer
BRD | Director/Board Member | 66 | 10-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 683 510 683 | 507 613 362 ( 74,27 %) | 173 930 493 ( 25,45 %) | 74,27 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ALVOTECH 1.03% | 2 735 145 | 1.03% | 37 963 813 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Baxter (India) Pvt Ltd.
Baxter (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Baxter (India) Pvt Ltd. manufactures recombinant and plasma-based proteins that are used to treat hemophilia and other bleeding disorders in India. The firm also offers plasma based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shocks, and other chronic and acute blood related conditions. It offers products to healthcare professionals, patients, and caregivers in the areas of anaesthesia, biosurgery, clinical nutrition, critical care, haemophilia, infusion systems, pharmaceuticals and IV solutions, renal, kidney disease, and immune deficiency. The company is headquartered in Gurgaon, India. |
Pharmaceuticals: Major
|
Baxter Innovations & Business Solutions Pvt Ltd.
| |
Baxter Pharmaceuticals India Pvt Ltd.
Baxter Pharmaceuticals India Pvt Ltd. Chemicals: Major DiversifiedProcess Industries Founded in 2005, Baxter Pharmaceuticals India Pvt Ltd. is a subsidiary of Baxter International, Inc. that manufactures chemical products. The company is based in Ahmedabad, India. |
Chemicals: Major Diversified
|
Gambro Lundia AB
Gambro Lundia AB Medical DistributorsDistribution Services Gambro Lundia AB operates as a medical technology company. It develops, manufactures, and distributes products and treatments for kidney and liver dialysis, treatment of myeloma kidney, and other extracorporeal treatments for chronically and acutely ill patients. The firm also holds shares in other companies. The company was founded on February 18, 1953 and is headquartered in Lund, Sweden. |
Medical Distributors
|
Baxter (Malta) Trading Co. Ltd.
| |
Baxter World Trade SRL
Baxter World Trade SRL Miscellaneous Commercial ServicesCommercial Services Founded in 1984, Baxter World Trade SRL is a Belgian company that provides management services. Part of Baxter International, Inc., the company is based in Lessines, Belgium. |
Miscellaneous Commercial Services
|
Baxter R & D Europe SRL
Baxter R & D Europe SRL Medical/Nursing ServicesHealth Services Founded in 1954, Baxter R & D Europe SRL is a subsidiary of Baxter International, Inc. that provides healthcare services. The company is based in Braine-l'Alleud, Belgium. |
Medical/Nursing Services
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,53% | 182 mld. | |
-4,01% | 103 mld. | |
-5,18% | 66,94 mld. | |
+9,07% | 46,73 mld. | |
-8,15% | 45,14 mld. | |
+5,82% | 41,57 mld. | |
+17,48% | 30,48 mld. | |
+14,00% | 24,26 mld. | |
-5,72% | 23,58 mld. |